Article Text

Download PDFPDF

Mechanisms of airway injury in COPD
S86 Formation of Oxidised Alpha-1 Antitrypsin Induces Inflammatory Response in Human Bronchial Epithelial Cells
  1. S Alam,
  2. Z Li,
  3. R Mahadeva
  1. University of Cambridge, Cambridge, UK


Alpha-1 antitrypsin (AT) is a major anti-elastase and protects the lung from uncontrolled elastolysis. AT is highly susceptible to oxidation in vivo. We investigated the role of Ox-AT in the inflammatory response.

Lung epithelial (A549 and NHBE) cells were exposed to 25% CSE. Ox-AT, TNF-α, IL-6, IL-8, MCP-1, NF-kB and AP-1 were assessed by ELISA or RT-PCR. Anti-Ox-AT mAb (3F4, 10µg/ml) and N-acetylcysteine (NAC, 10–3M) were used to probe the effect of Ox-AT.

CSE (compared to PBS) significantly induced TNF-α (440.4±76.8pg/ml vs. 17.5±2.6, p<0.001) at 24h and induced IL-6 at 72h (354.7±38.4pg/ml vs. 17.6±2, p<0.001). CSE induced TNF-α mRNA at 0.5h (p<0.001) and IL-6 mRNA at 3h (p<0.001). CSE (compared to PBS) activated NF-κB (OD at 405nm, 1.325 vs. 0.315, p<0.001) and AP-1 (OD at 405nm, 0.988 vs. 0.296, p<0.001) at 0.5h. At 24h CSE (compared to PBS) resulted in significant level of Ox-AT (mean±SEM, 1372.8±162.8ng/ml vs. undetectable, p<0.001) and induced IL-8 (1415.7±92.5pg/ml vs. 57.2±10, p<0.001) and MCP-1 (15683±713pg/ml vs. 2208±157, p<0.001). At 24h Ox-AT (compared to PBS) significantly induced IL-8 (1168±9pg/ml vs. 110±8, p=0.008) and MCP-1 (14500±424pg/ml vs. 4225±470, p=0.005) in A549 cells. NAC inhibited Ox-AT, TNF-α, IL-6, IL-8, MCP-1, NF-κB and AP-1 (p<0.001 for all). 3F4 selectively inhibited Ox-AT, IL-8, MCP-1, NF-κB and AP-1 (p<0.001 for all). These findings were confirmed with NHBE cells.

In conclusion, Ox-AT generated in the airway interacts directly with epithelial cells to release MCP-1 and IL-8, so enhancing lung inflammation. This mechanism could potentially contribute to the abnormal inflammatory response seen in COPD independent of CSE. Anti-oxidant treatment inhibited both CSE and Ox-AT induced inflammatory response further supporting a role for these agents in COPD.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.